Events2Join

Review Prognostic and Predictive Molecular Biomarkers in Chronic ...


Prognostic and Predictive Molecular Biomarkers in Chronic ...

Special emphasis will be put on predictive biomarkers related to newer targeted therapies in hopes that this review will serve as a useful reference for ...

Review Prognostic and Predictive Molecular Biomarkers in Chronic ...

This article focuses on the prognostic and predictive molecular biomarkers in CLL relevant to the molecular pathology practice.

Prognostic and Predictive Molecular Biomarkers in Chronic ...

Special emphasis will be put on predictive biomarkers related to newer targeted therapies in hopes that this review will serve as a useful ...

An Updated Perspective on Current Prognostic and Predictive ...

On the other hand, predictive biomarkers forecast disease response to specific treatments and are clinically useful in tailoring therapy. The purpose of this ...

Predictive and Prognostic Molecular Biomarkers in Familial Chronic ...

Background: Chronic lymphocytic leukemia (CLL) is the most common leukemia in the western world and the median age at diagnosis is 70 years.

Prognostic, Predictive Markers Have Growing Importance in CLL ...

In the review, Wang discusses both prognostic biomarkers, those that help indicate risk of disease development regardless of treatment, and ...

Predicting the outcome of patients with chronic lymphocytic ...

However, despite some progress to identify new predictive biomarkers, del(17p)/TP53 mutation remains the only widely accepted variable used to ...

Prognostic and predictive molecular biomarkers in advanced ...

In this Review, we focus on all these prognostic and predictive biomarkers, analyzing data from the most important clinical trials of the last years. We also ...

Recent progress of prognostic biomarkers and risk scoring systems ...

Table 2 Clinical significance of predictive biomarkers in chronic ... Study of microRNA profile as a molecular biomarker in Egyptian chronic ...

Tumor biomarkers for diagnosis, prognosis and targeted therapy

In recent years, extensive molecular and genetic characterization of disseminated tumor cells and blood-based biomarkers have contributed ...

Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer

In this review, we describe the different molecular markers in clinical use for CRC, highlight new markers that might become indispensable over the next years.

Prognostic and Predictive Molecular Biomarkers in Chronic ... - CoLab

Special emphasis will be put on predictive biomarkers related to newer targeted therapies in hopes that this review will serve as a useful ...

Assessing prognosis of chronic lymphocytic leukemia using ...

This review focuses on biomarkers revealed by investigations of CLL molecular genetics and immunogenetics, and that may help optimizing therapy for individual ...

Diagnostic, Predictive and Prognostic Molecular Biomarkers in ...

Despite the increasing number of biomarkers described in the literature, most of them have demonstrated moderate sensitivity and/or specificity ...

Prognostic and Predictive Biomarkers: Tools in Personalized Oncology

Biomarkers for personalized oncology are used mainly in molecular diagnostics of chronic myeloid leukemia, colon, breast and lung cancer, and recently in ...

New and emerging prognostic and predictive genetic biomarkers in ...

High-risk genetic biomarkers are four times more prevalent in adults compared to children. The application of genomic technologies to cases ...

Promising predictive molecular biomarkers for cervical cancer ...

The histopathological characteristics of tumors can effectively serve as prognostic markers of radiotherapy response; however, the efficacy rate ...

Molecular Biomarkers for Melanoma Screening, Diagnosis and ...

Similarly, predictive and prognostic tests may aim to determine disease trajectory and can assist in directing further intervention, such as follow up imaging ...

Incorporating molecular biomarkers into the continuum of care in ...

Prognostic and predictive biomarkers are then considered at subsequent major junctures, including at the time of treatment initiation, while on therapy, and at ...

Clinical utility of recently identified diagnostic, prognostic, and ...

Consequently, molecular genetic studies are increasingly being applied for the clinical workup of many of these neoplasms. In this review, we focus on the ...